arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

MiNK Therapeutics, Inc.

INKT

$9.65 ▼ -1.09 (-10.15%) at close

27 Visible periods

19 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bullish

auto_awesome

Analytical Summary

MiNK Therapeutics, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $48.5M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 18.1% →

FCF / Share $-0.41 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-2.74M

↑ +0.9% —

FCF / Share Free cash flow per share

$-0.41

↓ -5.2% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns ↑

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	41.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	18.6% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	12.9% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-41.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-45.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	36.4% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	89.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	69.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	59.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	35.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-162.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	21.1% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	—	-53.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	67.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	30.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	0.9% Caution ↓ Caution Declining Year-over-year change in net income	0.9% Caution ↓ Caution Declining Year-over-year change in net income	-5.6% Weak ↓ Weak Declining Year-over-year change in net income	27.4% Excellent ↓ Excellent Declining Year-over-year change in net income	27.4% Excellent ↓ Excellent Declining Year-over-year change in net income	27.4% Excellent ↓ Excellent Declining Year-over-year change in net income	54.9% Excellent ↑ Excellent Improving Year-over-year change in net income	32.9% Excellent → Excellent Stable Year-over-year change in net income	32.9% Excellent ↑ Excellent Improving Year-over-year change in net income	32.9% Excellent ↑ Excellent Improving Year-over-year change in net income	29.7% Excellent ↑ Excellent Improving Year-over-year change in net income	26.9% Excellent ↑ Excellent Improving Year-over-year change in net income	26.9% Excellent ↑ Excellent Improving Year-over-year change in net income	26.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-34.8% Weak ↑ Weak Improving Year-over-year change in net income	-102.2% Weak ↑ Weak Improving Year-over-year change in net income	-102.2% Weak ↑ Weak Improving Year-over-year change in net income	-102.2% Weak ↑ Weak Improving Year-over-year change in net income	-275.5% Weak Weak Year-over-year change in net income	12.4% Fair Fair Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	-5.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	-6.8% Weak ↓ Weak Declining Year-over-year change in free cash flow	—	72.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	36.1% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	53.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	—	38.2% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	49.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	43.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	—	27.0% Excellent Excellent Year-over-year change in free cash flow	11.5% Fair Fair Year-over-year change in free cash flow	—	—	-12.8% Weak Weak Year-over-year change in free cash flow	5.5% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.34x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.57x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	18.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	17.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	15.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	18.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	12.7% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	9.8% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	10.1% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	8.5% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	14.6% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	14.9% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	24.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	30.4% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	52.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	103.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	1553.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-93.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-44.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	13.8% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	7.0% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	4.2% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	2.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	9.1% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-33.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-63.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-43.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-55.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-120.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-35.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-36.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-20.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-15.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-33.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	19.5% Good → Good Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+30%)	21.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+44%)	18.3% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+22%)	20.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+36%)	11.0% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-27%)	12.7% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-15%)	12.6% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-16%)	21.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+45%)	23.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+53%)	18.8% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+25%)	30.2% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+102%)	41.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+179%)	59.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+299%)	127.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+747%)	—	-115.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-867%)	-56.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-479%)	-44.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-400%)	-24.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-262%)	5.0% Caution → Caution Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-66%)	6.1% Caution → Caution Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-59%)	6.7% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-55%)	2.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-81%)	8.6% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-43%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	-1608.45x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-720.45x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-93.29x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-127.34x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-150.09x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-93.13x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-83.42x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-67.31x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-118.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-748.61x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-906.11x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-1132.11x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-924.15x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-587.70x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-953.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8019.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-8696.10x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4112.17x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.97x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.22x Weak Weak Operating income divided by interest expense Optimal: > 5x	-9.27x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-8.81M	$-9.53M	$-13.36M	$-14.28M	—	$-3.23M	$-4.58M	—	—	$-5.82M	$-3.37M	—	—	$-14.89M	$-19.64M	—	—	$-34.69M	$-38.89M	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-0.62	$-0.57	$-0.54	$-0.65	$-1.06	$-0.70	$-0.62	$-0.46	$-0.73	$-1.10	$-6.04	$-1.50	$-1.80	$-1.70	$-2.30	$-1.90	$-1.80	—	$-1.50	$-5.90	$-2.60	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.41	$-0.36	—	$-0.21	$-0.39	$-0.34	—	$-0.76	$-0.62	$-0.73	—	$-1.23	$-1.22	$-1.29	—	$-1.68	$-1.38	—	—	$-1.49	$-1.46	—	—	—	—	—	—
Book Value per Share (USD)	$-2.75	$-2.64	—	$-3.04	$-6.33	$-5.50	—	$-4.44	$-4.46	$-5.86	$-5.22	$-3.94	$-2.76	$-1.32	$-0.12	$2.00	$4.07	—	$7.10	$-31.61	$-26.13	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$-2.75	$-2.64	—	$-3.04	$-6.33	$-5.50	—	$-4.44	$-4.46	$-5.86	$-5.22	$-3.94	$-2.76	$-1.32	$-0.12	$2.00	$4.07	—	$7.10	$-31.61	$-26.13	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	5.02M	4.80M	—	4.44M	3.98M	3.96M	—	3.95M	3.71M	3.46M	—	3.45M	3.44M	3.40M	—	3.38M	3.36M	—	—	2.42M	2.42M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$1.73M	$2.74M	$816.52K	$1.10M	—	$-8.54M	$-1.97M	—	—	$-5.11M	$-7.80M	—	—	$4.27M	$7.72M	—	—	$16.64M	$23.17M	—	—	—	$-10.13M	—	—	—	—
Total Equity (USD)	$-14.03M	$-12.69M	$-14.23M	$-13.51M	$-25.19M	$-21.79M	$-19.59M	$-17.55M	$-16.58M	$-20.30M	$-18.06M	$-13.58M	$-9.50M	$-4.48M	$-401.30K	$6.76M	$13.69M	$17.31M	$23.78M	$-76.51M	$-63.18M	$-57.08M	$-53.87M	$-51.34M	$-44.50M	$-40.06M	$-36.33M

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$36.06K	$36.07K	$38.56K	$43.65K	$48.76K	$50.77K	$53.87K	$62.64K	$45.10K	$53.83K	$53.57K	$53.45K	$51.91K	$45.69K	$37.93K	$28.43K	$28.31K	$27.08K	$23.83K	$20.29K	$17.65K	$16.19K	$16.14K	—	—	—	—
Net Income, GAAP (USD)	$-2.74M	$-2.74M	$-2.60M	$-2.77M	$-2.77M	$-2.77M	$-2.46M	$-3.81M	$-3.81M	$-3.81M	$-5.46M	$-5.69M	$-5.69M	$-5.69M	$-7.77M	$-7.78M	$-7.78M	$-7.78M	$-5.76M	$-3.85M	$-3.85M	$-3.85M	$-1.54M	$-4.39M	—	—	—
Operating Cash Flow (USD)	$-2.08M	$-1.73M	$-2.07M	$-941.35K	$-1.57M	$-1.34M	$-1.73M	$-2.99M	$-2.29M	$-2.54M	$-3.04M	$-4.21M	$-4.15M	$-4.37M	$-4.43M	$-5.61M	$-4.63M	$-4.20M	$-1.70M	$-3.50M	$-3.42M	$-4.21M	$-1.72M	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters

MiNK Therapeutics, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare INKT with peers